SCHEMBL9764904

SCHEMBL9764904

NC(=O)N(O)CCc1cc2oc3ccccc3c2cc1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.49
LMNA P02545 1/20 0.41
HTR2B P41595 1/20 0.40
KEAP1 Q14145 1/20 0.40
NPSR1 Q6W5P4 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPT P10636 2/20 0.38
HPGD P15428 2/20 0.38
AHR P35869 1/20 0.38
GAA P10253 1/20 0.38
MAOA P21397 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9764922 0.80 ALOX5 (0.49) ALOX5HTR2BNPSR1CYP1A2CYP2D6
SCHEMBL9764888 0.77 ALOX5 (0.75) ALOX5NPSR1KDM4EALDH1A1MAOA
SCHEMBL9764829 0.76 ALOX5 (0.41) ALOX5LMNACYP1A2KMT2AMEN1
SCHEMBL10561801 0.75 CYP1A2 (0.51) ALOX5HTR2BNPSR1CYP1A2CYP2D6
SCHEMBL10611641 0.73 HTR1A (0.47) ALOX5
SCHEMBL10611629 0.73 HTR1A (0.47) ALOX5
SCHEMBL9764809 0.71 PLA2G10 (0.40) ALOX5HTR2BCYP1A2CYP2D6CYP2C19
SCHEMBL3874960 0.70 AHR (0.59) ALOX5LMNANPSR1KMT2AMEN1
SCHEMBL9844863 0.70 SRD5A1 (0.47) LMNANPSR1KMT2AMEN1NPC1
SCHEMBL10560688 0.69 ALOX5 (0.49) ALOX5LMNACYP1A2CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0422079-A4 TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE 1991-08-21 EP disclosed
EP-0422079-A1 TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE ABBOTT LABORATORIES (US) 1991-04-17 EP disclosed
WO-1989012636-A1 TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE ABBOTT LABORATORIES (US) 1989-12-28 WO disclosed